Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.
| Autor: | Lavin L; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Dusza S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Geller S; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: gellers@mskcc.org. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of investigative dermatology [J Invest Dermatol] 2024 Jun 28. Date of Electronic Publication: 2024 Jun 28. |
| DOI: | 10.1016/j.jid.2024.06.1272 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|